US FDA stepping up enforcement of pharma ad rules, sends letters to companies

High -level management officials said in a statement on Tuesday that the US Food and Drug Administration would send about 100 stops and desist enforcement notifications and thousands of letters that advertisements for direct consumer should comply with the regulations in the books.

Authorities, FDA’s drug advertisements can not create a misleading impression about the products and should disclose the side effects in accordance with the plans to implement the arrangements, he said.

“According to the regulation, there are advertisements that make the line clearly in any future legal action, I think it is a very open section,” one of the authorities said. He said.
US President Donald Trump also signed a presidential memorandum on Tuesday afternoon, and the White House called on the administration directly to the consumer (DTC) drug advertisements to ensure transparency and accuracy.

USA Health and Human Services Secretary Robert F. Kennedy Jr. “Pharmaceutical advertisements tied this country to prescription drugs.” He said. He said: “This deception will close the pipeline and ask for all the critical security facts of pharmaceutical companies in advertisements.”

Phrma, the main lobby group of the industry, said that drug producers are dependent on correct and responsible ads that help Americans make conscious health decisions. “DTC advertising offers patients significantly based, useful and accessible information about potential treatment options.” He said. Presidential action and FDA letters coincide with Kennedy’s publication of the US Child Health Report by the Make America Again Commission of the USA.

Authorities added that the implementation of drug advertisements is increasingly loose and that FDA did not send any execution letter about drug advertising last year.

They did not explain which companies were sent to execution or warning letters. Not only ads from drug producers, but also advertisements from online pharmacies “ads that do not comply with the rules followed by many pharmaceutical companies”.

The government also examines the role of social media impressers in advertising and plans to close a gap that allows companies to direct patients to a website for information about side effects.

Administrative officials, the consumer directly planned for drug advertisements to the consumer, and the note that the note “patients to have sufficient safety information we can have the most powerful, bravest action,” he said.

In the first period, Trump tried to force a rule that would force pharmaceutical companies to include wholesale prices of their drugs in television advertisements.

US courts were on the side with drug producers Merck, Eli Lilly and Amgen and hit the rule.